Patent DE217599C successfully refreshed from Google Patents.
Patent US2045552A successfully refreshed from Google Patents.
Patent US3132992A successfully refreshed from Google Patents.
Patent US4035485A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4035485A Expired / Lapsed US ⏱️ 0.0 years remaining

Polypeptides

Assignee: Imperial Chemical Industries Ltd
•
Filing: 1975-08-18
•
Granted: 1977-07-12
•
Expires: 1995-08-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A polypeptide having 46 amino-acid residues and obtained by enzymic degradation of urogastrone. The polypeptide is a potent inhibitor of the secretion of acidic gastric juice.

Inventors

  • 👤 Harold Gregory
  • 👤 Beryl Margaret Preston

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 00:42
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/485; A; A61; A61P; A61P1/00; A61K; A61K38/00; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/911; Y10S930/00; Y10S930/01; Y10S930/12; Y10S930/26

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 17 words
The polypeptide of the formula: or its reduction product in which the cystine residues are reduced to
Claim 2
Dependent Claim 17 words
The polypeptide of the formula: or its reduction product in which the cystine residues are reduced to
Claim 3
Dependent Claim 19 words
A pharmaceutical composition for parenteral administration comprising a polypeptide or reduction product as claimed in claim 1 and a
Claim 4
Dependent Claim 22 words
A composition as claimed in claim 2 which is a sterile, injectable solution or suspension containing from 0.5 to 500 μg./ml. of
Claim 5
Dependent Claim 24 words
A pharmaceutical composition comprising from 10 to 200 μg. of sterile polypeptide or reduction product as claimed in claim 1 enclosed in a vial
Claim 6
Dependent Claim 34 words
A method of inhibiting the secretion of acidic gastric juice in warm blooded animals which comprises administering to said animal an effective amount of a polypeptide or reduction product as claimed in claim 1.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-11 1981-01-10 1981-07-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-11 1985-01-10 1985-07-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-11 1989-01-10 1989-07-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag